BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6583069)

  • 21. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium.
    Taetle R; Caviles A; Koziol J
    Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell substratum modulates responses of preosteoblasts to retinoic acid.
    Traianedes K; Ng KW; Martin TJ; Findlay DM
    J Cell Physiol; 1993 Nov; 157(2):243-52. PubMed ID: 8227157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation by retinoic acid of prostaglandin production and its inhibition by tumor promoters in mouse myeloid leukemia cells.
    Takenaga K
    Gan; 1981 Aug; 72(4):488-97. PubMed ID: 6946953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis.
    Aglietta M; Piacibello W; Stacchini A; Sanavio F; Gavosto F
    Leuk Res; 1985; 9(7):879-83. PubMed ID: 3860698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular aspects of proliferation and differentiation of human myeloid leukemia cell HL-60].
    Yamada M; Hashinaka K
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):41-53. PubMed ID: 1848717
    [No Abstract]   [Full Text] [Related]  

  • 27. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms.
    Turley JM; Falk LA; Ruscetti FW; Kasper JJ; Francomano T; Fu T; Bang OS; Birchenall-Roberts MC
    Cell Growth Differ; 1996 Nov; 7(11):1535-44. PubMed ID: 8930403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bone marrow fibroblasts on the proliferation and differentiation of myeloid leukemic cell lines.
    Stolze B; Emmendörffer A; Corbacioglu S; König A; Welte K; Ebell W
    Exp Hematol; 1995 Dec; 23(13):1378-87. PubMed ID: 7498367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of hydrocortisone on the production and differentiation of granulocyte/macrophage progenitor cells in long-term bone marrow cultures.
    Motomura S; Katsuno M; Kaneko S; Ibayashi H
    Exp Hematol; 1983 Jan; 11(1):56-62. PubMed ID: 6601022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal responsiveness of granulocyte macrophage committed stem cells from patients with chronic myeloid leukemia to proliferation inhibition by prostaglandin E 1.
    Rao SG; Nadkarni KS; Joshi K; Kothari V; Advani SH
    Indian J Exp Biol; 1984 Jun; 22(6):340-2. PubMed ID: 6595217
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulatory control of the proliferation ad differentiation of normal and leukemia cells.
    Metcalf D
    Natl Cancer Inst Monogr; 1982; 60():123-31. PubMed ID: 6981771
    [No Abstract]   [Full Text] [Related]  

  • 33. Human bone marrow granulocyte-macrophageal colonies (GM-Cs) in vitro: myeloid cells in health and in cases of myeloid leukemia.
    Zvetkova E; Savov Y; Gluhcheva Y; Ilieva I; Bichkidjieva E; Katzarova E; Tsenov I
    Clin Hemorheol Microcirc; 2004; 30(3-4):481-4. PubMed ID: 15258392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
    Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
    Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Special Education.
    Kozutsumi H
    Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: increased sensitivity in blastic phase of chronic myeloid leukemia.
    Januszewicz E; Rabizadah E; Maimon Z; Zaizov R; Shaklai M
    Pathology; 1988 Jan; 20(1):1-6. PubMed ID: 3163796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation and differentiation of normal and chronic myeloid leukaemia (CML) marrow cells in suspension cultures.
    Nilsson B; Olofsson T
    Scand J Haematol; 1984 Mar; 32(3):231-40. PubMed ID: 6583824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of inhibition of mouse myeloid leukemic cell differentiation by prostaglandin F2 alpha.
    Takenaga K; Honma Y; Kado J; Hozumi M
    Gan; 1982 Apr; 73(2):175-83. PubMed ID: 6956529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?
    Strife A; Clarkson B
    Semin Hematol; 1988 Jan; 25(1):1-19. PubMed ID: 3279512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.